Sensorion Announces the Availability of Its Financial Report for the 1st Half of 2023
26.09.2023 - Regulatory News: Sensorion (FR0012596468 – ALSEN), a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat, and prevent within the field of hearing loss disorders, Sensorion ...
Lang Schwarz Professeur Joseph Blayac Institut Pasteur Half Financial Report Financial Information Cochlear Limited
Source: wallstreet-online.de